NAL norwood abbey limited

Flu trial success menas NAL's immunology holding is worth over...

  1. 214 Posts.
    Flu trial success menas NAL's immunology holding is worth over 50 cents a share.

    Yesterday's announcmeent shows flu vaccine progressing to Phase II
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.